Advances in the treatment of immune checkpoint inhibitors for esophageal cancer
10.3760/cma.j.cn431274-20201102-01478
- VernacularTitle:免疫检查点抑制剂在食管癌治疗中的研究进展
- Author:
Xin TONG
1
;
Ligang XING
Author Information
1. 山东第一医科大学附属山东省肿瘤医院放疗科，济南 250117
- Keywords:
Esophageal neoplasms;
Immune checkpoint inhibitors;
Biomarkers
- From:
Journal of Chinese Physician
2022;24(1):142-145
- CountryChina
- Language:Chinese
-
Abstract:
As a new therapeutic strategy for esophageal cancer, immunotherapy has attracted more and more attention. The completed and ongoing clinical trials of immunotherapy for esophageal cancer confirm the great potential of immune checkpoint inhibitors in esophageal cancer. Future research will focus on the combination of immunotherapy with existing or new therapeutic modalities and the identification of populations likely to benefit from immunotherapy.
